Chronic kidney injury in patients after cardiac catheterisation or percutaneous coronary intervention: A comparison of radial and femoral approaches (from the British Columbia Cardiac and Renal Registries)

Heart

Volumn 96, Issue 19, 2010, Pages 1538-1542

  Vuurmans, Tycho ^a   Byrne, Jonathan ^b   Fretz, Eric ^a   Janssen, Christian ^c   Hilton, J David ^a   Klinke, W Peter ^a   Djurdjev, Ognjenka ^d   Levin, Adeera ^d  

^a ROYAL JUBILEE HOSPITAL   (Canada)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROMA; CLINICAL PROTOCOL; CONTROLLED STUDY; DIALYSIS; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; KIDNEY INJURY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIAL ARTERY; REGISTER; RISK FACTOR; SURGICAL APPROACH; SURGICAL TECHNIQUE; VASCULAR ACCESS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RADIAL ARTERY; REGISTRIES; RISK FACTORS;

EID: 77957303694     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.192294     Document Type: Article

References (31)

1. Brown JR, DeVries JT, Piper WD, et al. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J 2008;155:260-6.
2. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-19.
3. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75. (Pubitemid 27506242)
4. Lindsay J, Apple S, Pinnow EE, et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 2003;59:338-43.
5. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-8.
6. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64.
7. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003;42:211-16.
8. Drost H, Buis B, Haan D, et al. Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J 1984;52:339-42.
9. Scolari F, Ravani P, Gaggi R, et al. The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. Circulation 2007;116:298-304.
10. Freeman RV, O'Donnell M, Share D, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002;90:1068-73.
11. Nikolsky E, Mehran R, Turcot D, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004;94:300-5.
12. Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001;52:409-16.
13. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9.
14. Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269-75. (Pubitemid 27201945)
15. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44:349-56.
16. Pristipino C, Pelliccia F, Granatelli A, et al. Comparison of access-related bleeding complications in women versus men undergoing percutaneous coronary catheterization using the radial versus femoral artery. Am J Cardiol 2007;99:1216-21.
17. Karalis DG, Quinn V, Victor MF, et al. Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am Heart J 1996;131:1149-55.
18. Jaffe R, Hong T, Sharieff W, et al. Comparison of radial versus femoral approach for percutaneous coronary interventions in octogenarians. Catheter Cardiovasc Interv 2007;69:815-20.
19. Levin A, Djurdjev O, Duncan J, et al. Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 2006;21:370-7. (Pubitemid 43159990)
20. Komenda P, Beaulieu M, Seccombe D, et al. Regional implementation of creatinine measurement standardization. J Am Soc Nephrol 2008;19:164-9.
21. Inrig JK, Patel UD, Briley LP, et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrol Dial Transplant 2008;23:934-40.
22. Drey N, Roderick P, Mullee M, et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003;42:677-84.
23. Pristipino C, Trani C, Nazzaro MS, et al. Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study. Heart 2009;95:476-82.
24. Cantor WJ, Puley G, Natarajan MK, et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction-the RADIAL-AMI pilot randomized trial. Am Heart J 2005;150:543-9.
25. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004;93:1515-19. (Pubitemid 38749208)
26. Laskey WK, Jenkins C, Selzer F, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007;50:584-90.
27. Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 1998;32:1861-5.
28. Chase AJ, Fretz EB, Warburton WP, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit of reduced transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008;94:1019-25.
29. Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005;67:706-13.
30. Roy P, Raya V, Okabe T, et al. Incidence, predictors, and outcomes of postpercutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol 2008;101:1544-9.
31. Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009;119:495-502.